Apollo Hospitals Enterprise Ltd
Fundamental Score
Apollo Hospitals Enterprise Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of APOLLOHOSP across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (18.42%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (16.64%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Robust Profit Growth (25.98%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Consistent Growth Track Record (14.15% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (32.84% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (33.72% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Interest Coverage (6.22x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹3504.80 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 65.32%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 62.70x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Low Promoter Commitment (28.02%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Apollo Hospitals Enterprise Ltd
About APOLLOHOSP
Business Overview
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.
Company Details
Key Leadership
Corporate Events
Latest News
APOLLOHOSP Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP)?
As of 09 Feb 2026, 09:11 am IST, Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is currently trading at ₹7218.00. The stock has a market capitalization of ₹1.05L (Cr).
Is APOLLOHOSP share price Overvalued or Undervalued?
APOLLOHOSP is currently trading at a P/E ratio of 62.70x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Apollo Hospitals Enterprise Ltd share price?
Key factors influencing APOLLOHOSP's price include its quarterly earnings growth (Sales Growth: 12.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Apollo Hospitals Enterprise Ltd a good stock for long-term investment?
Apollo Hospitals Enterprise Ltd shows a 5-year Profit Growth of 33.72% and an ROE of 18.42%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.88 before investing.
How does Apollo Hospitals Enterprise Ltd compare with its industry peers?
Apollo Hospitals Enterprise Ltd competes with major peers in the Hospital. Investors should compare APOLLOHOSP's P/E of 62.70x and ROE of 18.42% against the industry averages to determine its competitive standing.
What is the P/E ratio of APOLLOHOSP and what does it mean?
APOLLOHOSP has a P/E ratio of 62.70x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹63 for every ₹1 of annual earnings.
How is APOLLOHOSP performing according to Bull Run's analysis?
APOLLOHOSP has a Bull Run fundamental score of 50.2/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does APOLLOHOSP belong to?
APOLLOHOSP operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Apollo Hospitals Enterprise Ltd.
What is Return on Equity (ROE) and why is it important for APOLLOHOSP?
APOLLOHOSP has an ROE of 18.42%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Apollo Hospitals Enterprise Ltd generates profits from shareholders' equity.
How is APOLLOHOSP's debt-to-equity ratio and what does it indicate?
APOLLOHOSP has a debt-to-equity ratio of 0.88, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is APOLLOHOSP's dividend yield and is it a good dividend stock?
APOLLOHOSP offers a dividend yield of 0.26%, which means you receive ₹0.26 annual dividend for every ₹100 invested.
How has APOLLOHOSP grown over the past 5 years?
APOLLOHOSP has achieved 5-year growth rates of: Sales Growth 14.15%, Profit Growth 33.72%, and EPS Growth 32.84%.
What is the promoter holding in APOLLOHOSP and why does it matter?
Promoters hold 28.02% of APOLLOHOSP shares, with 8.58% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is APOLLOHOSP's market capitalization category?
APOLLOHOSP has a market capitalization of ₹104826 crores, placing it in the Large-cap category.
How volatile is APOLLOHOSP stock?
APOLLOHOSP has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for APOLLOHOSP?
APOLLOHOSP has a 52-week high of ₹N/A and low of ₹N/A.
What is APOLLOHOSP's operating profit margin trend?
APOLLOHOSP has a 5-year average Operating Profit Margin (OPM) of 13.09%, indicating the company's operational efficiency.
How is APOLLOHOSP's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 12.78% and YoY Profit Growth of 25.98%.
What is the institutional holding pattern in APOLLOHOSP?
APOLLOHOSP has FII holding of 44.20% and DII holding of 21.12%. Significant institutional holding often suggests professional confidence in the stock.